Waarom bestaat er bij sommigen - in Groot-Brittannië en daarbuiten - een afkeer van Europa. Een mogelijk verklaring ligt in de exorbitante vergoedingen die uitgekeerd worden aan de Eurocraten.
Het kabinet spreekt alsnog grote waardering uit voor leden en nabestaanden van de Stay Behind-organisatie, een ultrageheime verzetsgroep die tijdens de Koude Oorlog klaarstond om het gewapend verzet te gaan vormen. Het is voor het eerst dat de Nederlandse regering publiekelijk de organisatie prijst.
Het kabinet spreekt alsnog grote waardering uit voor leden en nabestaanden van de Stay Behind-organisatie, een ultrageheime verzetsgroep die tijdens de Koude Oorlog klaarstond om het gewapend verzet te gaan vormen. Het is voor het eerst dat de Nederlandse regering publiekelijk de organisatie prijst.
EudraVigilance - Moderna covid MRNA vaccine up to 13/2/21Thierry Debels
This document summarizes data on 1,497 individual cases reported for the COVID-19 mRNA Vaccine Moderna (CX-024414) in EudraVigilance. The majority of cases were reported in individuals aged 18-64 (71.1%) and 65-85 (14.1%), with females representing 74.5% of cases. Most cases originated from countries in the European Economic Area (62.4%), with the remaining 37.6% from non-EEA countries. The data is broken down by age group, sex, geographic origin, and over time.
Mogelijke bijwerkingen Pfizer-vaccin Europa tot 13/2/21Thierry Debels
Over the last 12 months, EudraVigilance has identified over 30,000 individual cases of reactions to TOZINAMERAN, with the number of reported cases from EEA countries trending upwards and exceeding those from non-EEA countries. The dashboard displays the total number of cases over time and broken down by country and reaction type to monitor safety signals. Users are directed to key considerations on interpreting the results on the ADR reports website.
List of meetings Bill & Melinda Gates Foundation has held with Commissioners,...Thierry Debels
List of meetings Bill & Melinda Gates Foundation has held with Commissioners, Members of their Cabinet or
Director-Generals since 01/12/2014 under its current ID number in the Transparency Register:
371567915480-41.
This document contains summaries of data from EudraVigilance on individual cases reported over time and by different attributes. It includes charts and tables showing the number of cases by age group, sex, and geographic origin within and outside the European Economic Area, with females ages 18-64 making up the largest percentages.
BioNTech SE is a biopharmaceutical company that develops novel immunotherapies for cancer and other serious diseases. It has 2 employees who spend 25% of their time engaging with the European Commission and European Investment Bank regarding mRNA drugs and vaccines. BioNTech's annual costs for EU-related activities are between €50,000-99,999 and it received over €50 million in grants from Horizon 2020, FP7, and the EIB between 2019-2020.
Stad en OCMW Antwerpen - Meerjarenplan 2020-2025. aanpassing 2_bijlagenThierry Debels
Dading masterplan 2020 - Brabo II
Naar aanleiding van de uitvoering van de opdracht zijn tussen de opdrachtgevers enerzijds en de
opdrachtnemer anderzijds allerlei geschillen ontstaan. Ondanks vele onderhandelingen, resulteerde dit
in een patstelling. Om een jarenlange gerechtelijke procedure te vermijden, is er een dading
opgemaakt (2020_GR_00544).
De stad Antwerpen zal een bedrag van 20.000.000,00 euro aan de opdrachtnemer betalen. Dit werd
in voorliggende aanpassing voorzien op exploitatie.
Scenarios for the Future of Technology and International DevelopmentThierry Debels
This document is a report produced by The Rockefeller Foundation and Global Business Network that explores scenarios for the future of technology and international development. It presents four scenarios developed through a scenario planning process, which examines different ways that critical uncertainties around issues like political/economic alignments and adaptive capacity could influence the role of technology in development over the next 20 years. The scenarios - Lock Step, Clever Together, Hack Attack, and Smart Scramble - are meant to stimulate strategic thinking about both challenges and opportunities related to technology and development.
EudraVigilance - Moderna covid MRNA vaccine up to 13/2/21Thierry Debels
This document summarizes data on 1,497 individual cases reported for the COVID-19 mRNA Vaccine Moderna (CX-024414) in EudraVigilance. The majority of cases were reported in individuals aged 18-64 (71.1%) and 65-85 (14.1%), with females representing 74.5% of cases. Most cases originated from countries in the European Economic Area (62.4%), with the remaining 37.6% from non-EEA countries. The data is broken down by age group, sex, geographic origin, and over time.
Mogelijke bijwerkingen Pfizer-vaccin Europa tot 13/2/21Thierry Debels
Over the last 12 months, EudraVigilance has identified over 30,000 individual cases of reactions to TOZINAMERAN, with the number of reported cases from EEA countries trending upwards and exceeding those from non-EEA countries. The dashboard displays the total number of cases over time and broken down by country and reaction type to monitor safety signals. Users are directed to key considerations on interpreting the results on the ADR reports website.
List of meetings Bill & Melinda Gates Foundation has held with Commissioners,...Thierry Debels
List of meetings Bill & Melinda Gates Foundation has held with Commissioners, Members of their Cabinet or
Director-Generals since 01/12/2014 under its current ID number in the Transparency Register:
371567915480-41.
This document contains summaries of data from EudraVigilance on individual cases reported over time and by different attributes. It includes charts and tables showing the number of cases by age group, sex, and geographic origin within and outside the European Economic Area, with females ages 18-64 making up the largest percentages.
BioNTech SE is a biopharmaceutical company that develops novel immunotherapies for cancer and other serious diseases. It has 2 employees who spend 25% of their time engaging with the European Commission and European Investment Bank regarding mRNA drugs and vaccines. BioNTech's annual costs for EU-related activities are between €50,000-99,999 and it received over €50 million in grants from Horizon 2020, FP7, and the EIB between 2019-2020.
Stad en OCMW Antwerpen - Meerjarenplan 2020-2025. aanpassing 2_bijlagenThierry Debels
Dading masterplan 2020 - Brabo II
Naar aanleiding van de uitvoering van de opdracht zijn tussen de opdrachtgevers enerzijds en de
opdrachtnemer anderzijds allerlei geschillen ontstaan. Ondanks vele onderhandelingen, resulteerde dit
in een patstelling. Om een jarenlange gerechtelijke procedure te vermijden, is er een dading
opgemaakt (2020_GR_00544).
De stad Antwerpen zal een bedrag van 20.000.000,00 euro aan de opdrachtnemer betalen. Dit werd
in voorliggende aanpassing voorzien op exploitatie.
Scenarios for the Future of Technology and International DevelopmentThierry Debels
This document is a report produced by The Rockefeller Foundation and Global Business Network that explores scenarios for the future of technology and international development. It presents four scenarios developed through a scenario planning process, which examines different ways that critical uncertainties around issues like political/economic alignments and adaptive capacity could influence the role of technology in development over the next 20 years. The scenarios - Lock Step, Clever Together, Hack Attack, and Smart Scramble - are meant to stimulate strategic thinking about both challenges and opportunities related to technology and development.